What is the ROCE (Return on Capital Employed) of CSL this year?
The ROCE of CSL is 0.22 undefined this year.
CSL ROCE 2024
CSL ROCE
0.22
Ticker
CSL.AX
ISIN
AU000000CSL8
WKN
890952
In 2024, CSL's return on capital employed (ROCE) was 0.22, a 9.33% increase from the 0.2 ROCE in the previous year.
CSL Aktienanalyse
What does CSL do?
CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling CSL's Return on Capital Employed (ROCE)
CSL's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing CSL's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
CSL's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in CSL’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about CSL stock
How has the ROCE (Return on Capital Employed) of CSL developed compared to the previous year?
The ROCE of CSL has increased by 9.33% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of CSL?
A high Return on Capital Employed (ROCE) indicates that CSL has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of CSL?
A low ROCE (Return on Capital Employed) can indicate that CSL has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from CSL impact the company?
An increase in the ROCE of CSL can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of CSL affect the company?
A decrease in ROCE of CSL can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of CSL?
Some factors that can affect CSL's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of CSL so important for investors?
The ROCE of CSL is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can CSL take to improve the ROCE?
To improve the ROCE, CSL can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does CSL pay?
Over the past 12 months, CSL paid a dividend of 4 USD . This corresponds to a dividend yield of about 2 %. For the coming 12 months, CSL is expected to pay a dividend of 4.22 USD.
What is the dividend yield of CSL?
The current dividend yield of CSL is 2 %.
When does CSL pay dividends?
CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of CSL?
CSL paid dividends every year for the past 26 years.
What is the dividend of CSL?
For the upcoming 12 months, dividends amounting to 4.22 USD are expected. This corresponds to a dividend yield of 2.11 %.
In which sector is CSL located?
CSL is assigned to the 'Health' sector.
Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CSL from 10/2/2024 amounting to 2.203 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did CSL pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of CSL in the year 2023?
In the year 2023, CSL distributed 3.715 USD as dividends.
In which currency does CSL pay out the dividend?
The dividends of CSL are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The CSL stock can be added to a savings plan with the following providers: Consorsbank
Andere Kennzahlen von CSL
Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
